α-防御素检测在假体周围关节感染分期治疗后的临床评估
本研究回顾性分析了52例假体周围关节感染(PJI)分期治疗后在再植入术前接受α-防御素(AD)检测的患者,以2018年肌肉骨骼感染学会标准为金标准计算诊断准确性,并随访再植入术后按Delphi标准判定的治疗失败情况。AD检测敏感度为71%、特异度为97.78%,阳性预测值83.3%、阴性预测值95.65%。再植入的46例患者AD检测均为阴性,平均随访588天时9/46(19.5%)按Delphi标准判定为治疗失败。
要点
- PJI分期治疗后AD检测敏感度71%、特异度97.78%,阳性预测值83.3%、阴性预测值95.65%。
- 再植入的46例患者AD检测均为阴性,平均随访588天时9/46(19.5%)治疗失败。
- 作者认为需要进一步研究PJI分期治疗后的诊断检测及识别持续感染的验证标准。
核心结论
- AD检测在PJI分期治疗后应用时显示高特异度和高阴性预测值,但敏感度低。
- 需要进一步研究PJI分期治疗后的其他诊断检测,并需要用于识别持续感染的验证标准。
研究设计与样本
- 回顾性分析52例因PJI接受分期治疗并在再植入术前进行AD检测的患者。
- 以2018年肌肉骨骼感染学会标准作为金标准计算AD检测的诊断准确性。
- 通过病历回顾确定再植入术后是否按Delphi标准判定为治疗失败,平均随访588天。
主要发现
- AD检测诊断PJI的敏感度为71%、特异度为97.78%。
- AD检测的阳性预测值为83.3%、阴性预测值为95.65%。
- 接受再植入的46/52例患者AD检测结果均为阴性,其中9/46(19.5%)按Delphi标准判定为治疗失败,平均随访588天。
关键数值与推荐
- 以2018年肌肉骨骼感染学会标准作为诊断PJI的金标准。
- 治疗失败按Delphi标准定义。
- AD检测敏感度71%、特异度97.78%、阳性预测值83.3%、阴性预测值95.65%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要进一步研究PJI分期治疗后的AD检测及其他诊断检测。
- 作者指出需要用于识别PJI分期治疗后持续感染的验证标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosing persistent infection following staged treatment of prosthetic joint infection (PJI) is challenging. The alpha defensin (AD) test has been shown to be an accurate diagnostic test for the primary diagnosis PJI but has limited evaluation for use following a staged treatment of PJI. The goal of this study was to evaluate the diagnostic accuracy of AD testing following staged treatment of PJI before reimplantation surgery and to determine if negative AD test predicted success following reimplantation using Delphi Criteria at time of last follow-up. METHODS: Patients who underwent AD testing prior to reimplantation after staged treatment of PJI (n = 52) were reviewed. Preoperative data (AD result, synovial fluid [SF], C-reactive protein level [mg/L], SF culture, SF white blood cell count, % of polymorphonuclear lymphocytes, serum C-reactive protein/erythrocyte sedimentation rate) and intraoperative data (purulence and tissue culture) were reviewed and used to classify patients using 2018 Musculoskeletal Infectious Disease Society criteria for infection, which was then used as a gold standard test to calculate diagnostic accuracy. Chart review was used to determine if patients who underwent reimplantation surgery would go on to treatment failure as defined by Delphi Criteria. RESULTS: The sensitivity and specificity of AD test result as compared with Musculoskeletal Infectious Disease Society criteria in diagnosing PJI was calculated to be 71% and 97.78%. Positive predictive value was calculated to be 83.3%, and negative predictive value was calculated to be 95.65%. Patients who underwent reimplantation (46/52 patients) all had negative AD test results, and 9/46 or 19.5% would have treatment failure as defined by the Delphi Criteria with an average follow-up of 588 days. CONCLUSION: AD demonstrates high specificity and negative predictive value, with low sensitivity when utilized after staged treatment of PJI. Further investigation of this and other diagnostic tests following staged treatment of PJI is needed. Additionally, validated criteria used to identify persistent infection following staged treatment of PJI are required.
引用
- Stone WZ, Gray CF, Parvataneni HK, et al. Clinical Evaluation of Alpha Defensin Test Following Staged Treatment of Prosthetic Joint Infections. J Arthroplasty. 2019. PMID: 30952552. doi:10.1016/j.arth.2019.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。